Merck, Moderna Cancer Vaccine Breakthrough Could Be Catalyst the mRNA ETF Trade Has Been Waiting ForBenzinga • 08/19/26
Moderna or Merck: Which Soaring Cancer Vaccine Stock Is the Better Buy?Zacks Investment Research • 08/19/26
Stock Market Today, Aug. 19: Moderna Skyrockets 177% on Positive Phase 3 Melanoma DataThe Motley Fool • 08/19/26
Moderna stock price is skyrocketing on mRNA cancer vaccine trial news: Here's what's happeningFast Company • 08/19/26
Moderna's Cancer Breakthrough Just Made Tempus AI's $1.5 Billion Bet Look Brilliant24/7 Wall Street • 08/19/26
Moderna and Merck Just Made History With the First mRNA Cancer Vaccine to Succeed in a Phase 3 Trial. Here's What That Means for Investors.The Motley Fool • 08/19/26
Moderna shares soar as mRNA cancer vaccine succeeds in late-stage trialProactive Investors • 08/19/26
VIEW Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full resultsReuters • 08/19/26
Moderna Rockets 93%, Merck Jumps 7% as Melanoma Therapy Meets Primary Goal in Phase 3 Trial24/7 Wall Street • 08/19/26